Actively Recruiting
Preventing Early Ventilator-Associated Infections to Reduce Death in ICU Patients with Acute Brain Injuries A Randomized, Double-Blind, Placebo-Controlled Trial
Led by The George Institute · Updated on 2026-08-28
3300
Participants Needed
29
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
This research is focused on patients with acute severe brain injuries, such as those caused by stroke, traumatic injury, or oxygen loss after cardiac arrest, who require mechanical ventilation. It evaluates whether giving a single dose of a commonly used antibiotic soon after intubation can prevent infections in the airways and lungs, known as pneumonia, which is a common complication in these patients. The study aims to improve survival and recovery chances by preventing these infections early. Participants are randomly assigned to receive either a single intravenous dose of 2 grams of ceftriaxone diluted in at least 200 mL of 0.9% sodium chloride or a placebo an intravenous infusion of 0.9% sodium chloride without ceftriaxone shortly after intubation. This is a double-blind trial, meaning neither participants nor researchers know who receives the antibiotic or placebo. The treatment is given once shortly after the breathing tube is inserted. During the study, participants will be monitored for 90 days to measure overall survival and for 180 days to assess functional outcomes related to brain injury recovery. Researchers will collect data on survival rates, neurological function, length of mechanical ventilation, need for reintubation or tracheostomy, and other related health measures. The study also monitors safety and evaluates if antibiotic use affects outcomes and antibiotic resistance over time.
CONDITIONS
Brief Title
PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury
Research Team
T
Tina Schneider
D
Dorrilyn Rajbhandari
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here